Market Cap 421.53M
Revenue (ttm) 0.00
Net Income (ttm) -78.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 176,100
Avg Vol 261,216
Day's Range N/A - N/A
Shares Out 36.50M
Stochastic %K 69%
Beta N/A
Analysts Strong Sell
Price Target $35.00

Latest News on RAPP

Rapport semestriel Pilier 3 - 30 juin 2024

Sep 17, 2024, 2:35 AM EDT - 7 months ago

Rapport semestriel Pilier 3 - 30 juin 2024


J&J-backed Rapport Therapeutics raises $136 mln in US IPO

Jun 6, 2024, 7:57 PM EDT - 11 months ago

J&J-backed Rapport Therapeutics raises $136 mln in US IPO

JNJ


Rapport Therapeutics Seeks IPO For CNS Treatment Programs

May 22, 2024, 4:17 PM EDT - 1 year ago

Rapport Therapeutics Seeks IPO For CNS Treatment Programs